Enveda

Enveda is a biotechnology company that is learning from life’s chemistry to create better medicines faster. Enveda uses AI-powered tools to identify and characterize a wide range of molecules produced by living organisms—the vast majority of which have never been explored by science—creating a database of chemical biodiversity: the library of life. By growing, organizing, translating, and searching this unique library, Enveda learns from life’s evolved solutions to address today’s pressing medical needs. For more information on Enveda, visit enveda.com.

enveda.com

Enveda

enveda.com

HQUS

Team Size334

Open Jobs14

Total Funding-

Latest FundraiseUnknown

TL;DR

What they do: AI-driven drug discovery using natural-product/metabolomic chemistry

Founded / HQ: 2019, Boulder, Colorado

Stage / funding: Multiple rounds; announced $55M Series B (June 2024); total capital reported $230M

Team / scale: Founder & CEO: Viswa Colluru; Scientific Co‑Founder: Pieter Dorrestein; ~334 employees (reported)

Company Overview

Problem Domain

Drug discovery and development focused on natural products / metabolomics

Founded

2019

Industry

Biotechnology Research

Funding Track Record

Seed- December 2020

$4.9M

Seed round reported December 16, 2020 to build a medicinal-plant database

Series B2- June 14, 2024

$55M

Series B2 announced with new investors including Microsoft, The Nature Conservancy, Premji Invest and Lingotto; reported to bring total capital to $230M

Investor Signal

“Mix of venture and strategic investors including Microsoft, The Nature Conservancy, Premji Invest, Lingotto, Kinnevik, True Ventures, FPV, Level Ventures and Jazz Venture Partners”

Founders

What we do

TL;DR

Company Overview

Funding Track Record

Founders

What we do

Enveda

enveda.com

Enveda

enveda.com

HQUS

Team Size334

Open Jobs14

Total Funding-

Latest FundraiseUnknown

TL;DR

What they do: AI-driven drug discovery using natural-product/metabolomic chemistry

Founded / HQ: 2019, Boulder, Colorado

Stage / funding: Multiple rounds; announced $55M Series B (June 2024); total capital reported $230M

Team / scale: Founder & CEO: Viswa Colluru; Scientific Co‑Founder: Pieter Dorrestein; ~334 employees (reported)

Related Companies

Company	HQ	Industry	Total Funding
Velsera	🇺🇸US	BiotechnologyData and AnalyticsDeepTech	-
Isomorphic Labs	🇬🇧London, GB	BiotechnologyDeepTech	$602M
OrangeShark ATS	🇮🇳IN	Administrative ServicesCommerce and ShoppingHR and RecruitingInformation TechnologyProfessional Services	-
Jivi AI	🇮🇳Gurgaon, IN	Data and AnalyticsDeepTechHealthInformation TechnologyInternet ServicesSoftware	-
Daybreak	🇺🇸San Francisco, US	Data and AnalyticsDeepTechInformation TechnologySoftware	$112M

Company Overview

Problem Domain

Drug discovery and development focused on natural products / metabolomics

Founded

2019

Industry

Biotechnology Research

Funding Track Record

Seed- December 2020

$4.9M

Seed round reported December 16, 2020 to build a medicinal-plant database

Series B2- June 14, 2024

$55M

Series B2 announced with new investors including Microsoft, The Nature Conservancy, Premji Invest and Lingotto; reported to bring total capital to $230M

Investor Signal

“Mix of venture and strategic investors including Microsoft, The Nature Conservancy, Premji Invest, Lingotto, Kinnevik, True Ventures, FPV, Level Ventures and Jazz Venture Partners”

Founders

What we do

Related Companies

Company	HQ	Industry	Total Funding
Velsera	🇺🇸US	BiotechnologyData and AnalyticsDeepTech	-
Isomorphic Labs	🇬🇧London, GB	BiotechnologyDeepTech	$602M
OrangeShark ATS	🇮🇳IN	Administrative ServicesCommerce and ShoppingHR and RecruitingInformation TechnologyProfessional Services	-
Jivi AI	🇮🇳Gurgaon, IN	Data and AnalyticsDeepTechHealthInformation TechnologyInternet ServicesSoftware	-
Daybreak	🇺🇸San Francisco, US	Data and AnalyticsDeepTechInformation TechnologySoftware	$112M

Join the Team

Scientist, Bioanalyst

On-SiteHyderabad, Telangana, IN

On-Site • Hyderabad, Telangana, IN

Let’s build the future of medicine — together. Join Enveda as a Scientist

Bioanalyst(PK) in India and help us transform natural compounds into life-changing medicines.

We’re a team driven by curiosity and innovation—are you ready to make a difference?

What Makes Us EnvedaLife is smart, and we can learn from it. We’re reinventing drug discovery by harnessing nature’s intelligence. Our platform identifies new medicines four times faster than the industry standard—because patients can’t wait. What sets Enveda apart isn’t just what we do—it’s how we do it. Our culture is built on creativity, collaboration, and deep respect for each other. We believe “People Create All Value”, and our success is driven by the extraordinary team turning our mission into reality every day.

Our Momentum:

Teeming tracks opportunities at over 24,000 AI startups, then works with you to find (and land) the one you'll love.

Machine Learning Engineer

ContractUtrecht, NL

Contract • Utrecht, NL

Machine Learning Engineer

InternshipUtrecht, NL

Internship • Utrecht, NL

Machine Learning Engineer

Full-timeNiš, RS

Full-time • Niš, RS

AI Researcher

Full-timeCambridge, GB

Full-time • Cambridge, GB

Frontend Developer

ContractTel Aviv

Contract • Tel Aviv

DevOps Engineer

Full-timeManchester, GB

Full-time • Manchester, GB

Unicorn status: Achieved following a $150 million Series D funding round in 2025
Discovery and innovation: Advanced our first drug candidate to Phase 1 trials in 2024
Award-winning culture: Newsweek: Top 100 Global #MostLovedWorkplaces (2025) Forbes: America’s Best Startup Employers (2024 & 2025) Newsweek: America’s Greatest Startup Workplaces (2025)
LinkedIn: Top Startups to Watch (2024)

These milestones reflect the impact of our team and we’re just getting started, but they’re only possible because of the diverse talent, perspectives, and relentless drive of our team, and people like you.

Your Role in Our Mission:

At Enveda, every role drives impact. As a Scientist in our DMPK department, you’ll be at the forefront of delivering hope to patients everywhere. Your expertise in bioanalytical methods will be critical in accelerating our mission to transform drug discovery because every breakthrough starts with bold questions and brave actions.

What You’ll Do:

Independently operate and maintain LC-MS/MS instruments, troubleshooting as needed.
Develop, optimize, and validate bioanalytical methods for quantitative analysis of small molecules.
Analyze and interpret data, ensuring adherence to regulatory guidelines

We’re Looking For:

Master’s in Pharmaceutical Sciences, Analytical Chemistry, or a related field.
5 to 7 years of experience in DMPK/Drug Discovery bioanalytical department.
Hands-on experience with LC-MS/MS and HPLC

If you’re passionate about innovation and impact, we encourage you to apply—even if you don’t meet every requirement.

Our Values: Curiosity | Agency | Journey | Charity | Unity

Benefits: Culture | Medical | Block Leaves | Work-Life Harmony

At Enveda, we’re building a place where everyone can do the best work of their life. We are an equal opportunity employer and value diversity in all its forms.

👉Apply now and join a team committed to shaping the future of drug discovery.

Enveda is protecting Job Seekers

We care deeply about creating a safe, respectful experience for every applicant, so we wanted to share a few guidelines to help you spot anything that doesn’t feel right. You’ll always meet real Enveda team members through video or in-person conversations before receiving an offer.

All communication from us will come from an @enveda.com or @envedabio.com email address. We’ll never ask you to purchase equipment, send money, or share sensitive banking details as part of any step in our recruiting process.

If something feels off or you’re unsure whether a message is truly from Enveda, please reach out at anytime at recruiting@enveda.com.